INHBA and breast cancer: Furthermore, we show here that knocking down INHBA in metastatic breast cancer cells, decreased their migratory potential without affecting their proliferative capacity in vitro, delayed primary tumor growth formation and significantly suppressed formation of lung metastases in vivo.